Shopping Cart
Remove All
Your shopping cart is currently empty
Pomalidomide-amino-PEG3-NH2 is a synthesized compound comprising a conjugation between the E3 ligase ligand linker and Pomalidomide, a cereblon ligand. Designed for application in PROTAC technology, it incorporates a linker that enables effective binding with targeted proteins.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 100 mg | Inquiry | Backorder | Backorder | |
| 500 mg | Inquiry | Backorder | Backorder |
| Description | Pomalidomide-amino-PEG3-NH2 is a synthesized compound comprising a conjugation between the E3 ligase ligand linker and Pomalidomide, a cereblon ligand. Designed for application in PROTAC technology, it incorporates a linker that enables effective binding with targeted proteins. |
| In vitro | PROTACs are compounds comprising two distinct ligands connected by a linker: one ligand targets an E3 ubiquitin ligase, while the other targets a specific protein. Utilizing the intracellular ubiquitin-proteasome system, PROTACs selectively degrade target proteins [2]. |
| Synonyms | Pomalidomide-amino-PEG3-NH2 |
| Molecular Weight | 462.459 |
| Formula | C21H26N4O8 |
| Cas No. | 2380273-74-3 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.